The Impact of Economic Factors on the Pharmaceutical Industry - Where the Next Five Years Will Take Us
出 版 商：CBR Pharma Insights
出版日期：2011/03/15
頁 數：52頁
文件格式：PDF
價 格：
USD 3,900 (Single-User License)
USD 4,900 (Multi-User License)
USD 9,800 (Global-User License)
USD 4,900 (Multi-User License)
USD 9,800 (Global-User License)
The Impact of Economic Factors on the Pharmaceutical Industry - Where the Next Five Years Will Take Us
Summary
Although there is debate about the direction the US economy is headed, most analysts agree that though we are moving in towards a recovery, labor markets will be slow to rebound.
The economic downturn that we’re currently in has brought a number of challenges for the pharmaceutical industry, such as loss of health coverage through unemployment, decreasing health benefits for those still employed, and a lessened ability to pay for co-pays or prescriptions.
As a result, we are seeing increased issues of medication adherence by today’s patients. Moving forward, price pressures, from public payers, insurance companies and individuals, will lead many to replace branded products with generics. Due to these and other factors, the generics sector of the pharmaceutical industry is set to grow at a faster rate than the overall market.
“The Impact of Economic Factors on the Pharmaceutical Industry - Where the Next Five Years Will Take Us” is a consultancy-style report focused on the key economic issues affecting all pharmaceutical sectors and the various strategies companies are using to grow their business in these extremely challenging times.
Scope
- Economic overview and the healthcare reform
- Effect of the economy on patient adherence
- Effect of the economy on the generics market
- Review of key strategies related to manufacturing, R&D, and sales and marketing
- Impact of the shift towards emerging economies
- Future outlook
Reasons to buy
- Understand the key issues which will impact your business throughout the coming years
- Develop effective business strategies in areas such as patient adherence, generic competition, health care changes, and emerging markets
- Identify & exploit where and how you can support your brand and organization by taking aim at these key issues head on
- Gain access to a fully sourced executive assessment of the challenges being faced within pharma and the changes being seen throughout the industry which will impact your current and future revenue streams
- Compare strategies that your company is employing to grow the business with that of your competitors in these difficult economic times.
Summary
Although there is debate about the direction the US economy is headed, most analysts agree that though we are moving in towards a recovery, labor markets will be slow to rebound.
The economic downturn that we’re currently in has brought a number of challenges for the pharmaceutical industry, such as loss of health coverage through unemployment, decreasing health benefits for those still employed, and a lessened ability to pay for co-pays or prescriptions.
As a result, we are seeing increased issues of medication adherence by today’s patients. Moving forward, price pressures, from public payers, insurance companies and individuals, will lead many to replace branded products with generics. Due to these and other factors, the generics sector of the pharmaceutical industry is set to grow at a faster rate than the overall market.
“The Impact of Economic Factors on the Pharmaceutical Industry - Where the Next Five Years Will Take Us” is a consultancy-style report focused on the key economic issues affecting all pharmaceutical sectors and the various strategies companies are using to grow their business in these extremely challenging times.
Scope
- Economic overview and the healthcare reform
- Effect of the economy on patient adherence
- Effect of the economy on the generics market
- Review of key strategies related to manufacturing, R&D, and sales and marketing
- Impact of the shift towards emerging economies
- Future outlook
Reasons to buy
- Understand the key issues which will impact your business throughout the coming years
- Develop effective business strategies in areas such as patient adherence, generic competition, health care changes, and emerging markets
- Identify & exploit where and how you can support your brand and organization by taking aim at these key issues head on
- Gain access to a fully sourced executive assessment of the challenges being faced within pharma and the changes being seen throughout the industry which will impact your current and future revenue streams
- Compare strategies that your company is employing to grow the business with that of your competitors in these difficult economic times.
Executive Summary
Economic Overview
Where the economy is going
Employment figures and the pharmaceutical industry
The economy and health care behavior
National health care spending
Health Care Reform
Potential impact of the lack of health care reform
Controversy in the legislation
Challenges to the 2010 health care reform
Patient Adherence
The effect of the economy on adherence
What the pharmaceutical industry can do to help
Patient adherence as a public policy issue
Generics Market
The economy and the generics market
Government policy and generics
Growth of the generics market
Pharmaceutical Strategies
The internal pharmaceutical economy
Research and development
Manufacturing
Sales and marketing
Emerging Markets
Emerging markets can provide growth and savings
Mergers and acquisitions
Manufacturing and R&D
Sales force shift
Outlook for the Pharmaceutical Industry
Continuing challenges in the developed economies
The cautious potential in emerging markets
The need to adapt
Appendix
Economic Overview
Where the economy is going
Employment figures and the pharmaceutical industry
The economy and health care behavior
National health care spending
Health Care Reform
Potential impact of the lack of health care reform
Controversy in the legislation
Challenges to the 2010 health care reform
Patient Adherence
The effect of the economy on adherence
What the pharmaceutical industry can do to help
Patient adherence as a public policy issue
Generics Market
The economy and the generics market
Government policy and generics
Growth of the generics market
Pharmaceutical Strategies
The internal pharmaceutical economy
Research and development
Manufacturing
Sales and marketing
Emerging Markets
Emerging markets can provide growth and savings
Mergers and acquisitions
Manufacturing and R&D
Sales force shift
Outlook for the Pharmaceutical Industry
Continuing challenges in the developed economies
The cautious potential in emerging markets
The need to adapt
Appendix
